Equities

BioElectronics Corp

BIEL:PKL

BioElectronics Corp

Actions
  • Price (USD)0.0004
  • Today's Change0.000 / 60.00%
  • Shares traded80.46m
  • 1 Year change+14.29%
  • Beta0.9721
Data delayed at least 15 minutes, as of Nov 11 2024 20:17 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

BioElectronics Corporation is an electroceutical company. The Company develops wearables, neuromodulation devices to mitigate neurological diseases. Its pulsed shortwave therapy technology (PSWT) that uses low power pulsed electromagnetic fields regulate electrical activity of the nervous system. Its product line includes ActiPatch Musculoskeletal Pain Therapy, and RecoveryRx Post-operative and Chronic Wounds Therapy, which are sold by or on the order of medical professionals. Its flagship product, the ActiPatch Musculoskeletal Pain Therapy, is developed to relieve chronic pain. ActiPatch is a drug-free, wearable nonprescription medical device that provides 720-hours of on/off therapy. The Company is also focused on international customers to expand its distributions and sales. The neuromodulation basis of PSWT presents significant opportunities for it to develop optimized technology for diabetic neuropathy, postoperative surgery, chronic wounds, and other applications.

  • Revenue in USD (TTM)1.61m
  • Net income in USD-289.82k
  • Incorporated2000
  • Employees9.00
  • Location
    BioElectronics Corp4539 Metropolitan CtFREDERICK 21704-9452United StatesUSA
  • Phone+1 (301) 874-4890
  • Fax+1 (301) 874-6935
  • Websitehttps://www.bielcorp.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Predictive Oncology Inc1.75m-14.04m4.93m34.00--1.03--2.82-3.36-3.360.41580.71710.11081.454.2851,425.29-88.98-91.80-121.17-126.2960.2364.64-802.93-1,419.991.37--0.0634--18.244.7545.67--5.44--
Encision Inc6.56m-529.29k4.99m22.00--2.68--0.7599-0.045-0.0450.5560.15661.702.107.59298,337.30-13.69-3.03-19.50-4.1349.0051.25-8.06-1.891.01-8.890.1761---10.38-5.64-113.55---9.54--
Sharps Technology Inc0.00-8.21m5.05m3.00--0.5059-----10.88-10.880.005.550.00-------75.56---100.97----------0.6446--0.00-------112.12------
ADM Tronics Unlimited Inc3.06m-472.80k5.07m7.00--4.97--1.66-0.007-0.0070.04530.01511.113.725.67---17.14-15.22-29.35-22.0942.8741.15-15.45-18.580.8954--0.3259---19.35-0.3572-810.74------
Orgenesis Inc662.00k-29.02m5.34m146.00------8.07-8.68-8.680.2005-3.300.027278.295.384,534.25-122.18---1,312.10---101.06---4,489.28--0.0741-5.85-----98.53-50.94-271.82---17.71--
Bionoid Pharma Inc0.001.35m5.40m13.000.0882--3.99--1.131.130.00-0.1744-----------506.64--------------327.24---------31.55--26.01--
Aethlon Medical, Inc.0.00-11.50m5.62m14.00--0.6447-----3.87-3.870.000.62510.00----0.00-84.49-76.25-98.84-85.78-------2,246.87----0.00---100.00---1.43------
Agape ATP Corp1.38m-2.45m5.73m21.00--1.78--4.16-0.6396-0.63960.35990.83660.44648.2536.6665,621.91-78.78---111.56--64.23---176.47--4.66--0.0225---22.92---24.61------
Caduceus Software Systems Corp0.00-117.60k5.78m0.00---------0.0004-0.00040.00-0.00040.00-------402.19-11,090.31---------------76.88---------20,519.89------
Optimus Healthcare Services Inc1.89m-7.16m5.94m12.00------3.15-0.1744-0.17440.0454-0.18891.26--3.67157,291.70-477.28------85.93---379.51-----5.42----22.88---3.51------
Bioelectronics Corp1.61m-289.82k6.18m9.00------3.84-0.00002-0.000020.00007-0.00066.329.2014.53---113.86-383.59----49.4351.48-18.01-143.480.0099-0.4909----94.01-5.0975.01------
Biomerica Inc5.51m-6.16m6.56m63.00--1.23--1.19-0.3663-0.36630.32740.31780.52232.633.6987,412.70-58.44-44.68-71.68-51.738.8114.11-111.89-63.822.09--0.00--1.420.810916.27---7.64--
Dalrada Financial Corporation32.16m-21.34m6.79m0.00--0.7687--0.2111-0.2388-0.23880.35730.0911.098.863.37---75.10-80.63-239.06--30.1139.23-68.78-63.941.24-21.540.3452--54.35---43.94------
Neurometrix Inc4.38m-7.94m7.54m26.00--0.4333--1.72-5.50-5.502.918.580.21021.158.53168,600.80-38.06-23.24-40.80-27.2660.1959.17-181.03-48.8810.71--0.00---28.52-18.18-47.84--5.03--
Biotricity Inc12.24m-18.28m7.63m55.00------0.6235-1.74-1.741.18-1.272.121.678.08222,624.00-248.61-269.25----71.8958.93-117.41-258.940.106-0.6408----25.1597.8223.57------
Cutera Inc169.19m-148.97m7.82m430.00------0.0462-7.46-7.468.46-10.730.45722.083.86393,460.50-40.25-22.00-51.64-30.728.1847.63-88.05-27.242.17-31.342.05---15.865.47-97.76--85.87--
Data as of Nov 11 2024. Currency figures normalised to BioElectronics Corp's reporting currency: US Dollar USD

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Old Point Trust & Financial Services, NA (Invt Mgmt)as of 30 Sep 2024550.00k0.00%
Ethos Financial Group LLCas of 30 Sep 202420.00k0.00%
Old National Bank (Investment Management)as of 30 Sep 20240.000.00%
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.